Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment

Published:2018-03-08 Issue:11 Volume:57 Page:1449-1457
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Mogalian Erik^ORCID,Brainard Diana M.,Osinusi Anu,Moorehead Lisa,Murray Bernard,Ling Kah Hiing John,Perry Robert,Curtis Craig,Lawitz Eric,Lasseter Kenneth,Marbury Thomas,Mathias Anita

Funder

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s40262-018-0645-6/fulltext.html

Reference27 articles.

1. Manns MP, Buti M, Gane E, Pawlotsky J, Razavi H, Terrault N, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006.

2. Bhamidimarri KR, Satapathy SK, Martin P. Hepatitis C virus and liver transplantation. Gastroenterol Hepatol. 2017;13:214–20.

3. Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J Transl Int Med. 2017;5:8–17.

4. Majumdar A, Kitson MT, Roberts SK. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis. Aliment Pharmacol Ther. 2016;43:1276–92.

5. Davis GL. New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation. Liver Transpl. 2003;9:S114–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects;Current Pharmaceutical Biotechnology;2024-10

2. PBPK Evaluation of Sofosbuvir Dose in Pediatrics Using Simcyp®;Scientia Pharmaceutica;2023-08-10

3. Sustained virological response in an HCV-infected patient on an enzyme-inducing anti-epileptic agent despite undetectable trough plasma levels of velpatasvir;Journal of Hepatology;2023-05

4. Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor;Clinical Pharmacokinetics;2021-03-30

5. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis;Drug Safety;2020-11-03